Cargando…

Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research

The emergence of novel respiratory infections (e.g., COVID-19) and expeditious development of nanoparticle-based COVID-19 vaccines have recently reignited considerable interest in designing inhalable nanoparticle-based drug delivery systems as next-generation respiratory therapeutics. Among various...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Ho Wan, Chow, Stephanie, Zhang, Xinyue, Zhao, Yayi, Tong, Henry Hoi Yee, Chow, Shing Fung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review Article-theme
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072922/ https://www.ncbi.nlm.nih.gov/pubmed/37016029 http://dx.doi.org/10.1208/s12249-023-02559-y

Ejemplares similares

Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis
por: Shao, Zitong, et al.
Publicado: (2023)

Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline
por: Wong, Si Nga, et al.
Publicado: (2022)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
por: Debnath, Sujit Kumar, et al.
Publicado: (2018)

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations
por: Miyamoto, Kahori, et al.
Publicado: (2022)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
por: Sibum, Imco, et al.
Publicado: (2019)

Spray Dried Formulations for Inhalation—Meaningful Characterisation of Powder Properties
por: Jüptner, Angelika, et al.
Publicado: (2019)

Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery
por: Rashid, Md Abdur, et al.
Publicado: (2019)

Puerarin dry powder inhaler formulations for pulmonary delivery: Development and characterization
por: Rashid, Md Abdur, et al.
Publicado: (2021)

Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations
por: Pardeshi, Sagar R., et al.
Publicado: (2022)

Inhaled ciprofloxacin-loaded poly(2-ethyl-2-oxazoline) nanoparticles from dry powder inhaler formulation for the potential treatment of lower respiratory tract infections
por: Sabuj, Mohammad Zaidur Rahman, et al.
Publicado: (2021)

Stability of Inhaled Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticle Dry Powder Inhaler Formulation in High Stressed Conditions
por: Sabuj, Mohammad Zaidur Rahman, et al.
Publicado: (2022)

POxylated Dendrimer‐Based Nano‐in‐Micro Dry Powder Formulations for Inhalation Chemotherapy
por: Restani, Rita B., et al.
Publicado: (2018)

The Optimisation of Carrier Selection in Dry Powder Inhaler Formulation and the Role of Surface Energetics
por: Abiona, Olaitan, et al.
Publicado: (2022)

Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations
por: Knap, Karolina, et al.
Publicado: (2022)

An Overview on Spray-Drying of Protein-Loaded Polymeric Nanoparticles for Dry Powder Inhalation
por: Marante, Tânia, et al.
Publicado: (2020)

Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection
por: Rashid, Md Abdur, et al.
Publicado: (2021)

Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler
por: Salem, HF, et al.
Publicado: (2011)

Development of an Inhaled Sustained Release Dry Powder Formulation of Salbutamol Sulphate, an Antiasthmatic Drug
por: Kumaresan, C., et al.
Publicado: (2016)

Formulation and In Vitro and In Silico Characterization of “Nano-in-Micro” Dry Powder Inhalers Containing Meloxicam
por: Party, Petra, et al.
Publicado: (2021)

Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles
por: Varshosaz, Jaleh, et al.
Publicado: (2017)

Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
por: Liang, Wanling, et al.
Publicado: (2018)

Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
por: Stass, Heino, et al.
Publicado: (2013)

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
por: Chennakesavulu, S., et al.
Publicado: (2018)

A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis
por: Cheng, Shen Nam, et al.
Publicado: (2020)

State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization
por: Groß, Roman, et al.
Publicado: (2022)

Development of Solid Lipid Nanoparticles as Dry Powder: Characterization and Formulation Considerations
por: Santonocito, Debora, et al.
Publicado: (2023)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Understanding the Importance of Capsules in Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2021)

The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride
por: Benke, Edit, et al.
Publicado: (2021)

Spray-Dried Inhalable Powder Formulations of Gentamicin Designed for Pneumonic Plague Therapy in a Mouse Model
por: Zhu, Menghuan, et al.
Publicado: (2022)

Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers
por: Muralidharan, Priya, et al.
Publicado: (2014)

Concept review of dry powder inhalers: correct interpretation of published data
por: Price, David, et al.
Publicado: (2015)

Effect of Inhaler Design Variables on Paediatric Use of Dry Powder Inhalers
por: Lexmond, Anne J., et al.
Publicado: (2014)

Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
por: Acosta, Maria F., et al.
Publicado: (2020)

Moisture-Resistant Co-Spray-Dried Netilmicin with l-Leucine as Dry Powder Inhalation for the Treatment of Respiratory Infections
por: Cui, Yingtong, et al.
Publicado: (2018)

Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension
por: Zendehdel Baher, Shalaleh, et al.
Publicado: (2022)

Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder
por: Saha, Tushar, et al.
Publicado: (2022)

Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment
por: Lee, Wing-Hin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mdn7q9lga22gs7qh53gq8dhqqr